USA - NASDAQ:ARAV - US03890D1081 - Common Stock
ChartMill assigns a Buy % Consensus number of 43% to ARAV. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-08-22 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2023-08-03 | EF Hutton | Downgrade | Buy -> Hold |
| 2023-08-03 | William Blair | Downgrade | Outperform -> Market Perform |
| 2023-08-03 | BTIG | Downgrade | Buy -> Neutral |
| 2023-08-03 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-07-21 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-07-17 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-07-10 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-07-03 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-06-05 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-06-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-26 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-05-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-25 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-05-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-17 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-05-11 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-05-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-16 | HC Wainwright & Co. | Maintains | Buy |
| 2023-02-21 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-14 | EF Hutton | Maintains | Buy |
| 2023-01-05 | EF Hutton | Initiate | Buy |
| 2022-11-14 | Piper Sandler | Maintains | Overweight |
| 2022-10-25 | HC Wainwright & Co. | Maintains | Buy |
| 2022-06-03 | Roth Capital | Initiate | Buy |
| 2021-03-08 | BTIG | Initiate | Buy |
6 analysts have analysed ARAV and the average price target is 0.26 USD. This implies a price increase of 535.91% is expected in the next year compared to the current price of 0.0401.
The consensus rating for Aravive Inc (ARAV) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.